Correction to: Signal Transduction and Targeted Therapy https://doi.org/10.1038/s41392-021-00795-x, published online 19 November 2021
In this article1 Qing Wei should have been denoted as a corresponding author along with Huanlong Qin, but was inadvertently removed during the production process.
The original article has been corrected.
Reference
Gao, Y. et al. Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer. Sig. Transduct. Target Ther. 6, 398, https://doi.org/10.1038/s41392-021-00795-x (2021).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Gao, Y., Bi, D., Xie, R. et al. Correction To: Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer. Sig Transduct Target Ther 6, 434 (2021). https://doi.org/10.1038/s41392-021-00840-9
Published:
DOI: https://doi.org/10.1038/s41392-021-00840-9
This article is cited by
-
Harnessing gut microbiota for colorectal cancer therapy: from clinical insights to therapeutic innovations
npj Biofilms and Microbiomes (2025)
